{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:22:57Z","timestamp":1783164177259,"version":"3.54.6"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["3\/64_25"],"award-info":[{"award-number":["3\/64_25"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ctrv.2026.103160","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:37:30Z","timestamp":1779838650000},"page":"103160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic role of postoperative circulating tumor DNA in metastatic colorectal cancer treated with curative intent: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4502-1932","authenticated-orcid":false,"given":"Claudia","family":"Cardone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"de Oliveira Ascef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Cassata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso De","family":"Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Avallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2026.103160_b0005","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctrv.2026.103160_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0b013e3181b4539b","article-title":"Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients","volume":"250","author":"de Jong","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctrv.2026.103160_b0020","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70185","article-title":"Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights from the BLOODPAC Consortium","volume":"18","author":"Hadd","year":"2025","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ctrv.2026.103160_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2026.100462","article-title":"Harmonizing definitions in liquid biopsy: a terminology framework by the international society of liquid biopsy","volume":"12","author":"Jantus-Lewintre","year":"2026","journal-title":"J Liq Biopsy"},{"key":"10.1016\/j.ctrv.2026.103160_b0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","article-title":"ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group","volume":"33","author":"Pascual","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0035","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-25-01231","article-title":"Randomized phase II\/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 with Hepatectomy Alone for Liver Metastasis from Colorectal Cancer: Long-Term results of JCOG0603","author":"Kanemitsu","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41416-022-02017-9","article-title":"The utility of ctDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis","volume":"128","author":"Faulkner","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2026.103160_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062486","article-title":"Circulating Tumor DNA as a Real-Time Biomarker for Minimal Residual Disease and Recurrence Prediction in Stage II Colorectal Cancer: a Systematic Review and Meta-Analysis","volume":"26","author":"Negro","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctrv.2026.103160_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells12212520","article-title":"Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: a Systematic Review and Meta-Analysis","volume":"12","author":"Wullaert","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ctrv.2026.103160_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210230","article-title":"Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in patients Undergoing Curative-intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: a Systematic Review and Meta-Analysis","volume":"24","author":"Chidharla","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctrv.2026.103160_b0060","article-title":"Circulating tumor DNA as a predictive biomarker for colorectal cancer postsurgical recurrence: a systematic review and meta-analysis","author":"Khan","year":"2025","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0065","article-title":"A guide to systematic review and meta-analysis of prognostic factor studies","volume":"364","author":"Riley","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ctrv.2026.103160_b0070","doi-asserted-by":"crossref","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:ED000142.","DOI":"10.1002\/14651858.ED000142"},{"key":"10.1016\/j.ctrv.2026.103160_b0075","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ctrv.2026.103160_b0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ctrv.2026.103160_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1164","article-title":"Methods to estimate the between-study variance and its uncertainty in meta-analysis","volume":"7","author":"Veroniki","year":"2016","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ctrv.2026.103160_b0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"10.1016\/j.ctrv.2026.103160_b0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.ctrv.2026.103160_b0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/biomet\/37.3-4.256","article-title":"The Comparison of Percentages in Matched Samples","volume":"37","author":"Cochran","year":"1950","journal-title":"Biometrika"},{"key":"10.1016\/j.ctrv.2026.103160_b0105","unstructured":"Front Matter. Cochrane Handbook for Systematic Reviews of Interventions2019. p. i\u2013xxviii."},{"key":"10.1016\/j.ctrv.2026.103160_b0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ctrv.2026.103160_b0115","series-title":"Place of publication not identified","article-title":"Doing Meta-Analysis with R : a Hands-on Guide","author":"Harrer","year":"2021"},{"key":"10.1016\/j.ctrv.2026.103160_b0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ctrv.2026.103160_b0125","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ctrv.2026.103160_b0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ctrv.2026.103160_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103498","article-title":"Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases","volume":"70","author":"Bolhuis","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ctrv.2026.103160_b0140","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1080\/0284186X.2020.1806357","article-title":"Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer","volume":"59","author":"Boysen","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0145","article-title":"Postoperative circulating tumor DNA testing based on tumor na\u00efve strategy after liver metastasis surgery in colorectal cancer patients","volume":"13","author":"Jiang","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1418696","article-title":"Feasibility of ctDNA in detecting minimal residual disease and predicting recurrence for colorectal cancer liver metastases","volume":"14","author":"Kalil","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0155","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.annonc.2024.08.2240","article-title":"Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY","volume":"35","author":"Kataoka","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0160","doi-asserted-by":"crossref","DOI":"10.1111\/cas.16442","article-title":"Impact of Minimal Residual Disease on Early Recurrence of Liver Metastatic Colorectal Cancer","author":"Kawashima","year":"2025","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ctrv.2026.103160_b0165","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1097\/JS9.0000000000001236","article-title":"Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study","volume":"110","author":"Li","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.ctrv.2026.103160_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911529","article-title":"Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: an Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) patients Undergoing Surgical Resection","volume":"23","author":"Lonardi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctrv.2026.103160_b0175","article-title":"Detection of Molecular Residual Disease using Personalized Circulating Tumor DNA Assay in patients with Colorectal Cancer Undergoing Resection of Metastases. JCO Precis","volume":"5","author":"Loupakis","year":"2021","journal-title":"Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0180","article-title":"Circulating Tumor DNA as a Marker of Minimal Residual Disease after Radical Resection of Colorectal Liver Metastases","volume":"6","author":"Marmorino","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0185","article-title":"Circulating Tumor DNA Predicts Early Recurrence following Locoregional Therapy for Oligometastatic Colorectal Cancer","volume":"16","author":"O'Donnell","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctrv.2026.103160_b0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejca.2021.12.026","article-title":"Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: a prospective cohort study","volume":"163","author":"\u00d8gaard","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2026.103160_b0195","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1158\/1078-0432.CCR-23-3660","article-title":"Minimal Residual Disease using a Plasma-only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer following Curative intent Treatment","volume":"30","author":"Parikh","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2026.103160_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.109586","article-title":"A prospective study of methylated ctDNA in patients undergoing treatment for liver metastases from colorectal cancer","volume":"51","author":"Raunkilde","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0205","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/ijc.33924","article-title":"Circulating tumor DNA for prognosis assessment and postoperative management after curative-intent resection of colorectal liver metastases","volume":"150","author":"Reinert","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2026.103160_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003620","article-title":"Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: a prospective cohort study","volume":"18","author":"Tie","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.ctrv.2026.103160_b0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s43856-025-00852-4","article-title":"Clinical utility and future perspectives of liquid biopsy in colorectal cancer","volume":"5","author":"Patelli","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.ctrv.2026.103160_b0220","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging Biological Principles of Metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ctrv.2026.103160_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102991","article-title":"Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience","volume":"9","author":"Moretto","year":"2024","journal-title":"ESMO Open"},{"issue":"125\u201336","key":"10.1016\/j.ctrv.2026.103160_b0230","first-page":"e3","article-title":"Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer","volume":"33","author":"Yaeger","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctrv.2026.103160_b0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0240","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1467-985X.2008.00593.x","article-title":"Multivariate Meta-Analysis: the effect of ignoring Within-Study Correlation","volume":"172","author":"Riley","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"10.1016\/j.ctrv.2026.103160_b0245","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12885-020-6710-1","article-title":"Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases","volume":"20","author":"Siebenhuner","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctrv.2026.103160_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102735","article-title":"Waiting for the \u201cliquid revolution\u201d in the adjuvant treatment of colon cancer patients: a review of ongoing trials","volume":"126","author":"Conca","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctrv.2026.103160_b0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ctrv.2026.103160_b0260","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41591-025-03579-w","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial","volume":"31","author":"Tie","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ctrv.2026.103160_b0265","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ijc.35442","article-title":"Utility of circulating tumor DNA to detect minimal residual disease in colorectal cancer: a systematic review and network meta-analysis","volume":"157","author":"Hoang","year":"2025","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2026.103160_b0270","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.4_suppl.TPS310","article-title":"NRG-GI008: colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-North America)","volume":"43","author":"Lieu","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0275","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1016\/j.annonc.2025.08.1298","article-title":"723O Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients: final results of the PEGASUS trial","volume":"36","author":"Marsoni","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.2024.42.3_suppl.5","article-title":"Phase II results of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA) phase II\/III study","volume":"42","author":"Morris","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0285","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial","author":"Tie","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ctrv.2026.103160_b0290","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1038\/s41591-025-04030-w","article-title":"Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2\/3 DYNAMIC-III trial","volume":"31","author":"Tie","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ctrv.2026.103160_b0295","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.4_suppl.LBA22","article-title":"A randomized, double-blind, phase III study comparing trifluridine\/tipiracil (FTD\/TPI) versus placebo in patients with molecular residual disease following curative resection of colorectal cancer (CRC): the ALTAIR study","volume":"43","author":"Bando","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41571-024-00967-y","article-title":"Minimal residual disease as a target for liquid biopsy in patients with solid tumours","volume":"22","author":"Pantel","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0305","article-title":"Circulating Tumor DNA as a Cancer Biomarker: an Overview of Biological Features and Factors that may Impact on ctDNA Analysis. Front","volume":"12","author":"Sanchez-Herrero","year":"2022","journal-title":"Oncol"},{"key":"10.1016\/j.ctrv.2026.103160_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2026.03.005","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","author":"Cremolini","year":"2026","journal-title":"Ann Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:00:41Z","timestamp":1783162841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737226000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"alternative-id":["S0305737226000745"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103160","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic role of postoperative circulating tumor DNA in metastatic colorectal cancer treated with curative intent: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103160"}}